R Baserga Selected Research

Oligodeoxyribonucleotides

4/2001

Results of a pilot study involving the use of an antisense oligodeoxynucleotide directed against the insulin-like growth factor type I receptor in malignant astrocytomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

R Baserga Research Topics

Disease

4	Prostatic Neoplasms (Prostate Cancer) 01/2001 - 04/2000
3	Neoplasms (Cancer) 04/2001 - 07/2000
1	Glioma (Gliomas) 04/2001
1	Astrocytoma (Pilocytic Astrocytoma) 04/2001
1	Wounds and Injuries (Trauma) 03/2001
1	Insulin Resistance 02/2001
1	Adenocarcinoma 09/2000

Drug/Important Bio-Agent (IBA)

3	Somatomedin Receptors (Somatomedin Receptor)IBA 03/2001 - 05/2000
2	Insulin-Like PeptidesIBA 04/2001 - 09/2000
2	Insulin-Like Growth Factor I (IGF-1)IBA 02/2001 - 09/2000
2	IGF Type 1 Receptor (IGF 1 Receptor)IBA 05/2000 - 04/2000
1	Proteins (Proteins, Gene)FDA Link 04/2001
1	OligodeoxyribonucleotidesIBA 04/2001
1	CanavanineIBA 04/2001
1	Amino Acids FDA Link 04/2001
1	Insulin Receptor Substrate ProteinsIBA 01/2001
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 07/2000
1	Interleukin-3 (Interleukin 3)IBA 07/2000

Therapy/Procedure

1	Craniotomy 04/2001
1	Prostatectomy (Retropubic Prostatectomy) 09/2000